Covered recipient · General Payments record
AMANDA CRANDELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021
$539.61
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $539.61 | 31 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $206.25 | 6 |
| Lilly USA, LLC | $121.45 | 7 |
| ABBVIE INC. | $117.41 | 12 |
| Amarin Pharma Inc. | $37.80 | 2 |
| Merck Sharp & Dohme Corporation | $27.58 | 2 |
| GlaxoSmithKline, LLC. | $15.12 | 1 |
| Acerta Pharma LLC | $14.00 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $539.61 | 31 |
Payment records · PY2021 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2021
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $0.89 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517771 | CMS |
| AbbVie Inc. | $17.95 | 03/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517773 | CMS |
| AbbVie Inc. | $14.37 | 03/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517775 | CMS |
| AbbVie Inc. | $6.90 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517777 | CMS |
| AbbVie Inc. | $10.87 | 04/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517779 | CMS |
| AbbVie Inc. | $10.77 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517781 | CMS |
| AbbVie Inc. | $13.33 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517783 | CMS |
| AbbVie Inc. | $2.37 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517785 | CMS |
| AbbVie Inc. | $5.28 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517787 | CMS |
| AbbVie Inc. | $10.24 | 06/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517789 | CMS |
| AbbVie Inc. | $9.84 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517791 | CMS |
| AbbVie Inc. | $14.60 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796517793 | CMS |
| Amarin Pharma Inc. | $20.39 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815401359 | CMS |
| Amarin Pharma Inc. | $17.41 | 02/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815351649 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.00 | 01/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830073713 | CMS |
| GlaxoSmithKline, LLC. | $15.12 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802377857 | CMS |
| Lilly USA, LLC | $16.99 | 01/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818786619 | CMS |
| Lilly USA, LLC | $15.13 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818832571 | CMS |
| Lilly USA, LLC | $18.46 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818831435 | CMS |
| Lilly USA, LLC | $17.32 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818786621 | CMS |
| Lilly USA, LLC | $18.08 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818769769 | CMS |
| Lilly USA, LLC | $15.63 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818832569 | CMS |
| Lilly USA, LLC | $19.84 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818786617 | CMS |
| Merck Sharp & Dohme Corporation | $15.42 | 04/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848556623 | CMS |
| Merck Sharp & Dohme Corporation | $12.16 | 05/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848410907 | CMS |
| Novo Nordisk Inc | $9.81 | 01/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811430981 | CMS |
| Novo Nordisk Inc | $17.77 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811045045 | CMS |
| Novo Nordisk Inc | $18.20 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810881913 | CMS |
| Novo Nordisk Inc | $24.25 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810881921 | CMS |
| Novo Nordisk Inc | $21.60 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811045051 | CMS |
| Novo Nordisk Inc | $114.62 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811312529 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.